{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:36:30Z","timestamp":1793219790664,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","award":["PMRF fellowship (PMRF ID 1702160)"],"award-info":[{"award-number":["PMRF fellowship (PMRF ID 1702160)"]}],"id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbc.2026.113487","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:32:46Z","timestamp":1787700766000},"page":"113487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rewiring mitotic checkpoint control via Mps1 inhibition overcomes DNA repair-mediated resistance in glioblastoma"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2976-7411","authenticated-orcid":false,"given":"Gaurav","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-7602","authenticated-orcid":false,"given":"Sivapriya","family":"Kirubakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113487_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00412-012-0378-5","article-title":"Connecting up and clearing out: how kinetochore attachment silences the spindle assembly checkpoint","volume":"121","author":"Kops","year":"2012","journal-title":"Chromosoma"},{"key":"10.1016\/j.jbc.2026.113487_bib2","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1038\/ncomms9987","article-title":"Kinetochore\u2013microtubule attachment is sufficient to satisfy the human spindle assembly checkpoint","volume":"6","author":"Etemad","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113487_bib3","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1242\/jcs.094763","article-title":"BubR1 blocks substrate recruitment to the APC\/C in a KEN-box-dependent manner","volume":"124","author":"Lara-Gonzalez","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbc.2026.113487_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrm3494","article-title":"Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore","volume":"14","author":"Foley","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10896","article-title":"Structure of the mitotic checkpoint complex","volume":"484","author":"Chao","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113487_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1083\/jcb.201205170","article-title":"Mad2 and the APC\/C compete for the same site on Cdc20 to ensure proper chromosome segregation","volume":"199","author":"Izawa","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/15384101.2016.1148842","article-title":"The hairpin region of Ndc80 is important for the kinetochore recruitment of Mph1\/Mps1 in fission yeast","volume":"15","author":"Chmielewska","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.113487_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.devcel.2017.03.025","article-title":"Mps1 regulates kinetochore-microtubule attachment stability via the Ska complex to ensure error-free chromosome segregation","volume":"41","author":"Maciejowski","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.113487_bib9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113487_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.113487_bib11","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1073\/pnas.94.26.14361","article-title":"The anaphase inhibitor of Saccharomyces cerevisiae Pds1p is a target of the DNA damage checkpoint pathway","volume":"94","author":"Cohen-Fix","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113487_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4161\/cc.5.9.2726","article-title":"BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers Paclitaxel resistance","volume":"5","author":"Chabalier","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2026.113487_bib13","doi-asserted-by":"crossref","first-page":"17108","DOI":"10.1073\/pnas.0407585101","article-title":"A requirement for breast cancer-associated gene 1 (BRCA1) in the spindle checkpoint","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113487_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.molcel.2011.09.016","article-title":"Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint","volume":"44","author":"Yang","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2026.113487_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/genetics\/161.2.521","article-title":"Overlapping roles of the spindle assembly and DNA damage checkpoints in the cell-cycle response to altered chromosomes in Saccharomyces cerevisiae","volume":"161","author":"Garber","year":"2002","journal-title":"Genetics"},{"key":"10.1016\/j.jbc.2026.113487_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000015","article-title":"DNA damage activates the SAC in an ATM\/ATR-Dependent manner, independently of the kinetochore","volume":"4","author":"Kim","year":"2008","journal-title":"Plos Genet."},{"key":"10.1016\/j.jbc.2026.113487_bib17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0960-9822(02)01226-5","article-title":"DNA damage during mitosis in human cells delays the Metaphase\/Anaphase transition via the spindle-assembly checkpoint","volume":"12","author":"Mikhailov","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib18","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1128\/MCB.25.17.7889-7899.2005","article-title":"The Fission yeast Crb2\/Chk1 Pathway coordinates the DNA damage and spindle checkpoint in response to replication stress induced by topoisomerase I inhibitor","volume":"25","author":"Collura","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib19","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/sj.onc.1209392","article-title":"BubR1 is involved in regulation of DNA damage responses","volume":"25","author":"Fang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113487_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cub.2009.12.033","article-title":"Mad2 prolongs DNA damage checkpoint arrest caused by a double-strand break via a centromere-dependent mechanism","volume":"20","author":"Dotiwala","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1083\/jcb.201306023","article-title":"DNA replication and spindle checkpoints cooperate during S phase to delay mitosis and preserve genome integrity","volume":"204","author":"Magiera","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ng.2007.64","article-title":"Unprotected Drosophila melanogaster telomeres activate the spindle assembly checkpoint","volume":"40","author":"Musar\u00f2","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.113487_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113487_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/1471-2164-13-664","article-title":"An S\/T-Q cluster domain census unveils new putative targets under Tel1\/Mec1 control","volume":"13","author":"Cheung","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jbc.2026.113487_bib25","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1074\/jbc.M410152200","article-title":"TTK\/hMps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68","volume":"280","author":"Wei","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib26","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/onc.2008.477","article-title":"The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK\/hMps1","volume":"28","author":"Yeh","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113487_bib27","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/nar\/gkq1210","article-title":"USP7\/HAUSP stimulates repair of oxidative DNA lesions","volume":"39","author":"Khoronenkova","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113487_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/nar\/gkv1173","article-title":"Requirement for human Mps1\/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation","volume":"44","author":"Yu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113487_bib29","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/MCB.01837-08","article-title":"TTK\/hMps1 mediates the p53-Dependent postmitotic checkpoint by phosphorylating p53 at Thr18","volume":"29","author":"Huang","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib30","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jbc.2026.113487_bib31","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1073\/pnas.97.12.6242","article-title":"Glioblastoma multiforme: the terminator","volume":"97","author":"Holland","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113487_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.jbc.2026.113487_bib33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","article-title":"Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study","volume":"27","author":"Mohammed","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"10.1016\/j.jbc.2026.113487_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874467211205010102","article-title":"Temozolomide: mechanisms of action, repair and resistance","volume":"5","author":"Zhang","year":"2012","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2026.113487_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma: 5-year analysis of the EORTC\u2013NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2026.113487_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2026.113487_bib37","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the treatment of glioblastoma Multiforme\u2014A literature review and clinical outcomes","volume":"31","author":"Jezierza\u0144ski","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jbc.2026.113487_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jnci\/djt168","article-title":"Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs","volume":"105","author":"Tannous","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbc.2026.113487_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"Carter","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2026.113487_bib40","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1158\/0008-5472.CAN-14-3272","article-title":"Naturally occurring mutations in the MPS1 gene predispose cells to kinase inhibitor drug resistance","volume":"75","author":"Gurden","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113487_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14744\/ejmo.2024.54846","article-title":"Mps1 knockdown in glioblastoma induces DNA damage and up regulation of histone methyltransferase SETD2","volume":"8","author":"Jema\u00e0","year":"2024","journal-title":"Eurasian J. Med. Oncol."},{"key":"10.1016\/j.jbc.2026.113487_bib42","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1541-7786.MCR-14-0462-T","article-title":"Targeting MPS1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins","volume":"13","author":"Maachani","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113487_bib43","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopha.2016.08.004","article-title":"HLF\/miR-132\/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells","volume":"83","author":"Chen","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2026.113487_bib44","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.18632\/oncotarget.23152","article-title":"Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma","volume":"9","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.113487_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12885-022-09899-1","article-title":"TTK protein kinase promotes temozolomide resistance through inducing autophagy in glioblastoma","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2026.113487_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.201006080","article-title":"A chemical toolbox defines mitotic and interphase roles for Mps1 kinase","volume":"190","author":"Lan","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib47","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/cdd.2013.105","article-title":"Characterization of novel MPS1 inhibitors with preclinical anticancer activity","volume":"20","author":"Jema\u00e0","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2026.113487_bib48","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41416-018-0081-2","article-title":"Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division","volume":"118","author":"Maia","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2026.113487_bib49","article-title":"Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: deep insights from a decade of research and patents. Eur","volume":"273","author":"Liang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13402-026-01175-9","article-title":"Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma","volume":"49","author":"de Gooijer","year":"2026","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jbc.2026.113487_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroscience.2022.03.030","article-title":"Recent advances in the therapeutic strategies of glioblastoma multiforme","volume":"491","author":"Aldoghachi","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2026.113487_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.695325","article-title":"Critical view of novel treatment strategies for glioblastoma: failure and success of resistance mechanisms by glioblastoma cells","volume":"9","author":"Burster","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101474","article-title":"Generation of phenothiazine with potent Anti-TLK1 activity for prostate cancer therapy","volume":"23","author":"Singh","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2026.113487_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-86599-3","article-title":"TLK1 as a therapeutic target in TMZ resistant glioblastoma using small molecule inhibitor","volume":"15","author":"Priya","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113487_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107643","article-title":"A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy","volume":"151","author":"Priya","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1083\/jcb.201001036","article-title":"Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine","volume":"190","author":"Santaguida","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib57","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-11-0453","article-title":"Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1","volume":"10","author":"Tardif","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2026.113487_bib58","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1016\/j.bmcl.2012.04.131","article-title":"Lead optimization of purine-based orally bioavailable Mps1 (TTK) inhibitors","volume":"22","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.113487_bib59","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1016\/j.bmcl.2013.10.008","article-title":"Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads","volume":"23","author":"Bursavich","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.113487_bib60","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmc.2017.02.030","article-title":"Novel pyrrolopyrimidines as Mps1\/TTK kinase inhibitors for breast cancer","volume":"25","author":"Sugimoto","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib61","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1021\/acs.jmedchem.7b01223","article-title":"The discovery of a dual TTK protein Kinase\/CDC2-Like kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen","volume":"60","author":"Riggs","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib62","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1021\/acs.jmedchem.8b01869","article-title":"Design and optimization leading to an orally active TTK protein kinase inhibitor with robust single agent efficacy","volume":"62","author":"Riggs","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib63","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1021\/acs.jmedchem.1c00635","article-title":"Structure-Guided optimization provides a series of TTK protein inhibitors with potent antitumor activity","volume":"64","author":"Elsner","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib64","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1021\/acs.jmedchem.1c00542","article-title":"X-ray crystal structure-guided design and optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile scaffold as a potent and orally active monopolar spindle 1 inhibitor","volume":"64","author":"Lee","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114887","article-title":"Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer","volume":"245","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113487_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064498","article-title":"Restoration of sensitivity in chemo \u2014 resistant glioma cells by cold atmospheric plasma","volume":"8","author":"K\u00f6ritzer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.113487_bib67","doi-asserted-by":"crossref","first-page":"20232","DOI":"10.1073\/pnas.0710519105","article-title":"Autophosphorylation-dependent activation of human Mps1 is required for the spindle checkpoint","volume":"104","author":"Kang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113487_bib68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nchembio.345","article-title":"Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function","volume":"6","author":"Kwiatkowski","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib69","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1158\/0008-5472.CAN-10-2101","article-title":"Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase","volume":"70","author":"Colombo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113487_bib70","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1093\/nar\/gks670","article-title":"Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis","volume":"40","author":"Enoiu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113487_bib71","first-page":"71","article-title":"DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: Bleomycin, neocarzinostatin and other enediynes","volume":"355","author":"Povirk","year":"1996","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jbc.2026.113487_bib72","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1038\/s41598-022-09614-x","article-title":"Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma","volume":"12","author":"Ganesa","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.113487_bib73","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ncb884","article-title":"DNA damage-induced G2\u2013M checkpoint activation by histone H2AX and 53BP1","volume":"4","author":"Fernandez-Capetillo","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib74","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","article-title":"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage","volume":"10","author":"Paull","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib75","first-page":"111","article-title":"Mitotic protein kinase 1: role in spindle assembly checkpoint revisited","volume":"1","author":"Tandle","year":"2016","journal-title":"J. Cancer Clin. Trials"},{"key":"10.1016\/j.jbc.2026.113487_bib76","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1158\/1078-0432.CCR-20-4185","article-title":"A phase I Study of an MPS1 inhibitor (BAY 1217389) in combination with Paclitaxel using a novel randomized continual reassessment method for dose escalation","volume":"27","author":"Atrafi","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113487_bib77","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.1700234114","article-title":"Functional characterization of CFI-402257, a potent and selective Mps1\/TTK kinase inhibitor, for the treatment of cancer","volume":"114","author":"Mason","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113487_bib78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00485","article-title":"Discovery of Pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent","volume":"7","author":"Liu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2026.113487_bib79","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jmb.2017.05.014","article-title":"Target residence time-guided optimization on TTK kinase results in inhibitors with potent anti-proliferative activity","volume":"429","author":"Uitdehaag","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.113487_bib80","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/ijms25063217","article-title":"A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance","volume":"25","author":"Karve","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113487_bib81","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.jbc.2026.113487_bib82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/biomedicines7040092","article-title":"On the critical issues in temozolomide research in glioblastoma: clinically relevant concentrations and MGMT-independent resistance","volume":"7","author":"Stepanenko","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2026.113487_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s13402-021-00613-0","article-title":"DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets","volume":"44","author":"Lozinski","year":"2021","journal-title":"Cell Oncol"},{"key":"10.1016\/j.jbc.2026.113487_bib84","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1038\/s41598-018-22744-5","article-title":"High yield bacterial expression, purification and characterisation of bioactive Human tousled-like Kinase 1B involved in cancer","volume":"8","author":"Bhoir","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826023598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826023598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:29:49Z","timestamp":1793219389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826023598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0021925826023598"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113487","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rewiring mitotic checkpoint control via Mps1 inhibition overcomes DNA repair-mediated resistance in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113487"}}